Houlihan Lokey, Inc.

Houlihan Lokey, Inc. (HLI) Market Cap

Houlihan Lokey, Inc. has a market capitalization of $8.77B.

Price: $125.49

-2.85 (-2.22%)

Market Cap: 8.77B

NYSE · time unavailable

CEO: Scott Joseph Adelson

Sector: Financial Services

Industry: Investment - Banking & Investment Services

IPO Date: 2015-08-13

Website: https://www.hl.com

Houlihan Lokey, Inc. (HLI) - Company Information

Market Cap: 8.77B|Sector: Financial Services

Company Profile

Houlihan Lokey, Inc. is a prominent global investment banking firm offering a comprehensive suite of financial advisory services. These include expertise in mergers and acquisitions (M&A), capital markets, financial restructuring, and valuation. The company's operations are divided into three core segments: The Corporate Finance division provides broad financial guidance. It assists both public and private entities with strategic buy-side and sell-side transactions and a variety of capital-raising activities, such as leveraged loans, private mezzanine debt, high-yield debt, initial public offerings (IPOs), follow-on offerings, convertibles, equity private placements, and private equity investments. This segment also advises financial sponsors on diverse deal structures and liability management initiatives. The Financial Restructuring segment guides debtors, creditors, and other involved parties through complex recapitalization and deleveraging processes. Its specialized advisory services encompass the design, negotiation, and confirmation of reorganization plans, the structuring and analysis of exchange offers, corporate viability assessments, expert testimony for dispute resolution, and the procurement of debtor-in-possession (DIP) financing. The Financial and Valuation Advisory group specializes in appraising various asset types, including entire businesses, illiquid debt and equity securities, and intellectual property. It delivers critical fairness opinions for M&A and other transactions, as well as solvency opinions for corporate spin-offs and dividend recapitalizations, alongside other financial assessments. This segment further contributes to dispute resolution services. Established in 1972, Houlihan Lokey serves a diverse clientele, including corporations, institutions, and governmental entities. Headquartered in Los Angeles, California, the firm maintains a significant international presence with offices located across the United States, Europe, the Middle East, and the Asia-Pacific region.

Analyst Sentiment

78%
Strong Buy

From 11 Active Polls

1Y Forecast: $168.25

▲ +34.1% Potential Upside

Consensus Target Metrics

Low Bound

$148

Median

$169

High Bound

$187

Average

$168

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$168.25
▲ +34.07% Upside
Low Target
$148.00
18% Risk
Median Target
$169.00
35% Mid
High Target
$187.00
49% Max
Consensus
Buy
9 / 15 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingTrailing 12MJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024
Market Cap ($M)8,7708,9209,52811,60713,74911,92110,69411,43210,401
Enterprise Value ($M)8,5188,6688,83111,04813,25811,56710,16111,06610,141
Price to Earnings Ratio (P/E)20.6128.6623.9424.8830.7430.6021.9429.9427.82
Price/Earnings-to-Growth Ratio (PEG)2.853.444.352.892.33
Price to Sales Ratio (P/S)3.4817.4614.9916.1920.8519.6916.0518.0218.09
Price to Book Ratio (P/B)3.703.964.075.066.125.474.925.495.31
Price to Free Cash Flow Ratio (P/FCF)18.10-26.0833.2253.4842.59-82.3231.1043.6937.32
Enterprise Value to Sales (EV/Sales)16.9613.8915.4120.1019.1115.2517.4417.64
Enterprise Value to EBITDA (EV/EBITDA)14.33100.7961.9459.2173.9580.2057.9669.8369.87
Debt to Equity Ratio-0.420.220.210.220.190.200.200.210.22

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 HOULIHAN LOKEY INC CLASS A (HLI) — Investment Overview

🧩 Business Model Overview

Houlihan Lokey is a transaction-focused advisory firm. The company serves corporate and investor clients across major value-creation events—mergers and acquisitions, fairness opinions, restructuring, and valuation. Work flows from client origination (relationships and referrals), to mandate execution (analyst/modeling teams, industry specialists, and senior deal leadership), to fee realization (primarily success-based advisory fees and milestone-based deliverables).

A key feature of the model is that expertise is embedded in engagements: deal teams develop institutional knowledge about counterparties, assets, leverage profiles, and negotiation dynamics. That “knowledge continuity” creates client stickiness, supporting repeat mandates and cross-service opportunities (e.g., valuation informing restructuring or M&A negotiations).

💰 Revenue Streams & Monetisation Model

  • Transaction advisory (M&A / capital advisory): fees typically tied to completion and/or defined milestones, making revenue inherently cyclical with deal volume and credit conditions.
  • Restructuring and advisory: mandates often respond to credit stress and capital structure complexity; fees can be milestone-driven and tied to outcomes across creditor and equity negotiations.
  • Valuation & fairness / dispute-related services: more recurring in nature than pure deal-completion work, supported by ongoing requirements for financial reporting, litigation, and purchase/sale processes.
  • Consulting and other professional services: supplemental services that leverage the same research and modeling capabilities while broadening the client footprint.

Margin drivers are primarily (i) utilization of senior and junior professionals, (ii) project economics on complex mandates, and (iii) compensation structure (variable components tied to performance and realization). Because the firm’s cost base is heavily labor-driven, operating leverage depends on deal flow and the ability to keep high-quality staffing aligned with demand.

🧠 Competitive Advantages & Market Positioning

HLI’s durable moat is best characterized as switching costs and intangible client trust rather than technology-led defensibility. Specialized expertise in valuation and restructuring creates repeat engagement dynamics: once a client entrusts a mandate, the incumbent benefits from accrued knowledge, established processes, and a proven track record under time-sensitive and high-scrutiny situations.

  • Greenhill & Co. (GHL): competes for advisory mandates and restructuring work, typically with a boutique positioning. HLI’s competitive focus emphasizes scale in valuation and restructuring depth, supporting broader cross-sell across investor and corporate clients.
  • Lazard (LAZ): competes strongly in high-profile M&A and strategic advisory, with a brand anchored in senior-led deal execution. HLI often differentiates through more pronounced specialization in restructuring and valuation services where credibility and documented work product matter.
  • Evercore (EVR): competes in M&A and strategy advisory with a professional-services model and industry coverage. HLI’s relative positioning leans toward credit-sensitive and technically complex advisory areas that favor established specialists and proven outcomes.

Overall, HLI operates with a focus on advisory segments where credibility, modeling rigor, and execution track record are central. These attributes are difficult for new entrants to replicate quickly, reinforcing client retention and widening the pipeline through referrals.

🚀 Multi-Year Growth Drivers

Across a 5–10 year horizon, growth is supported by structural demand for independent advisory in complex corporate actions:

  • Persistent deal complexity: multinational transactions, heightened diligence requirements, and evolving stakeholder expectations increase the need for high-quality valuation and advisory.
  • Credit cycle re-normalization: restructuring and capital structure advisory demand expands in periods of leverage stress, refinancing pressure, and covenant renegotiations—segments where specialized expertise commands mandates.
  • Valuation-driven transactions and reporting needs: fair value measurement, impairment considerations, and transaction-related valuation work maintain baseline demand independent of pure M&A cycles.
  • Private capital activity: private equity and private markets increase the frequency of portfolio restructurings, exits, and complex acquisition modeling—creating recurring sources of valuation and advisory work.
  • Cross-service client relationships: mandates in restructuring, valuation, and M&A can share analysts, templates, and data sets, enabling efficiency in onboarding new projects for existing clients.

TAM expansion is less about “new markets” and more about increased penetration of advisory outsourcing and the need for specialized independent counsel as transaction and balance-sheet complexity rises.

⚠ Risk Factors to Monitor

  • Advisory cyclicality: transaction volumes and credit stress severity drive fee activity; downturns can reduce utilization and revenue.
  • Competition from banks and boutiques: large-cap investment banks and specialized boutiques can win mandates through pricing, balance-sheet relationships, or sector specialization.
  • Execution and reputational risk: advisory outcomes and credibility are paramount; client losses or public disputes can impair the pipeline.
  • Regulatory and compliance burdens: financial reporting requirements, professional conduct oversight, and marketing/solicitation rules can increase compliance costs and restrict certain practices.
  • Human capital concentration: as a professional-services firm, performance depends on recruiting, retaining, and scaling senior talent; compensation pressure can rise during tight labor markets.

📊 Valuation & Market View

Equity markets typically value advisory firms based on normalized earnings power rather than short-cycle earnings, given the business’s exposure to deal activity and credit conditions. Common valuation frameworks include earnings or enterprise-value-based multiples (e.g., EV/EBITDA or P&E-related measures) that reflect expected operating leverage, workforce scalability, and long-term fee capacity.

Key valuation drivers include (i) the durability of client relationships and mandate win rates, (ii) margin resilience through compensation discipline and utilization management, and (iii) balance between transaction-dependent revenue and more stable valuation/restructuring-related services.

🔍 Investment Takeaway

Houlihan Lokey’s long-term case rests on specialized expertise in valuation and restructuring and the resulting client switching costs tied to trust, documentation, and execution history. While revenue generation remains cyclical with capital markets and credit conditions, the firm’s positioning supports repeat engagement dynamics and cross-sell potential—factors that can sustain earnings capacity through market cycles.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for HLI.

defenseworld.net2026-08-01

Argent Capital Management LLC Lowers Holdings in Houlihan Lokey, Inc. $HLI

Argent Capital Management LLC decreased its stake in shares of Houlihan Lokey, Inc. (NYSE: HLI) by 14.3% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 202,422 shares of the financial services provider's stock after selling 33,673 shares during the period. Argent Capital Management

marketbeat.com2026-07-30

Houlihan Lokey Q1 Earnings Call Highlights

Houlihan Lokey NYSE: HLI reported first-quarter fiscal 2027 revenue of $511 million and adjusted earnings per share of $1.35, with management characterizing the quarter as a temporary disruption rather than a fundamental change in its outlook.

zacks.com2026-07-29

Houlihan Lokey (HLI) Misses Q1 Earnings and Revenue Estimates

Houlihan Lokey (HLI) came out with quarterly earnings of $1.35 per share, missing the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $2.14 per share a year ago.

seekingalpha.com2026-07-29

Houlihan Lokey, Inc. (HLI) Q1 2027 Earnings Call Transcript

Houlihan Lokey, Inc. (HLI) Q1 2027 Earnings Call Transcript

zacks.com2026-07-29

Houlihan Lokey (HLI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for Houlihan Lokey (HLI) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

businesswire.com2026-07-29

Houlihan Lokey Reports First Quarter Fiscal 2027 Financial Results

LOS ANGELES--(BUSINESS WIRE)--Houlihan Lokey, Inc. (NYSE:HLI) (“Houlihan Lokey” or the “Company”) today reported financial results for its first quarter ended June 30, 2026. For the first quarter ended June 30, 2026, revenues were $511 million, compared with $605 million for the first quarter ended June 30, 2025. Net income attributable to Houlihan Lokey, Inc. was $78 million, or $1.15 per diluted share, for the first quarter ended June 30, 2026, compared with $98 million, or $1.42 per diluted.

seekingalpha.com2026-07-27

Houlihan Lokey: Cautious Expectations For Q1 Advisory

Houlihan Lokey (HLI) will show the pressures of the environment on results in a few days' time. The issue is that being mid-market and therefore sponsor indexed, and also tech indexed, not a lot is going right for them when there's upside risk on cost of capital. Restructuring activity may sequentially improve, but robust US macro conditions limit major upside.

zacks.com2026-07-22

Analysts Estimate Houlihan Lokey (HLI) to Report a Decline in Earnings: What to Look Out for

Houlihan Lokey (HLI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

businesswire.com2026-07-09

Houlihan Lokey Bolsters Equity Capital Solutions Capabilities With Senior Hire

NEW YORK--(BUSINESS WIRE)--Dan Buffery has joined Houlihan Lokey's Capital Solutions team as a Managing Director to help lead North American GP-led secondaries advisory.

businesswire.com2026-07-08

Houlihan Lokey Announces Release Date for First Quarter Results for Fiscal Year 2027

LOS ANGELES--(BUSINESS WIRE)--Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, today announced that it will release its first quarter results for the 2027 fiscal year on Wednesday, July 29, 2026, after the close of trading on the New York Stock Exchange. Houlihan Lokey will host a conference call at 5:00 p.m. (ET) that same day to review the results. On the call, Scott Adelson, Chief Executive Officer, and Lindsey Alley, Chief Financial Officer, will discuss the fiscal 2027 first qu.

zacks.com2026-07-01

Houlihan Lokey Bets on Energy Advisory Growth With Intrepid Buyout

HLI expands its energy investment banking franchise with the Intrepid acquisition, strengthening advisory capabilities in a resilient dealmaking market.

gurufocus.com2026-06-30

Houlihan Lokey to Acquire Intrepid Financial Partners

Houlihan Lokey, Inc. (NYSE: HLI), the global investment bank, has agreed to acquire Intrepid Financial Partners, LLC (Intrepid), a premier independent investment

businesswire.com2026-06-30

Houlihan Lokey to Acquire Intrepid Financial Partners

HOUSTON & NEW YORK--(BUSINESS WIRE)--Houlihan Lokey has agreed to acquire Intrepid Financial Partners, LLC, an independent investment bank focused on the energy sector.

businesswire.com2026-06-24

Morningstar Indexes & Houlihan Lokey to Launch Daily Valued Index Suite for the Collateralized Loan Obligation (CLO) Market.

CHICAGO--(BUSINESS WIRE)--Morningstar, Inc. (NASDAQ: MORN), a leading provider of independent investment insights and market data, today announced a strategic collaboration with leading global investment bank Houlihan Lokey (NYSE: HLI) to develop a new suite of daily valuation indexes to help investors measure and invest in collateralized loan obligations (CLOs).Through this new initiative, Morningstar Indexes will work with Houlihan Lokey's Portfolio Valuation and Fund Advisory Services team to.

seekingalpha.com2026-06-05

Dividend Champion, Contender, And Challenger Highlights: Week Of June 7

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-06-30

"Headlines (2026-06-30, Q1): Revenue $511.0M and Net Income $78.0M; EPS $1.17 (diluted $1.15). YoY: Revenue +(511.0-605.3)/605.3 = -15.5% and Net Income + (78.0-97.5)/97.5 = -20.0%. QoQ: Revenue fell from $635.6M to $511.0M (-19.6%) and Net Income declined from $99.8M to $78.0M (-21.9%). Profitability was weaker: net margin compressed to 15.3% from 15.7% in Q4’26 (and down vs 16.1% a year ago), and gross margin normalized lower (30.7% vs 98.7% in the immediately prior quarter), indicating elevated quarter-to-quarter volatility in reported cost structure. Cash flow quality deteriorated sharply in Q1: operating cash flow was -$336M and free cash flow was -$342M, contrasting with positive OCF in Q4’26 ($293M) and Q3/Q2’26. Despite the cash outflow, the balance sheet remains equity-heavy and low-leverage: net debt is negative (net cash) at about -$252M, while total assets rose to $3.72B and total equity was $2.37B. Shareholder distributions continued with dividends paid of -$61M, but buybacks were not reported this quarter. Total shareholder returns were positive on price (+6.8% 1y) but not momentum-led; total return signals are modest. Analyst valuation looks stretched: P/E ~28.7x vs consensus target $168.25 (below current), implying limited near-term upside."

Revenue Growth

Neutral

Q1’27 revenue declined -19.6% QoQ and -15.5% YoY (from $635.6M and $605.3M, respectively), indicating a clear near-term downtrend.

Profitability

Caution

Net margin eased to 15.3% in Q1’27 from 15.7% in Q4’26 and ~16.1% YoY; earnings momentum also weakened with Net Income -21.9% QoQ and -20.0% YoY.

Cash Flow Quality

Neutral

Operating cash flow swung to -$336M in Q1’27 (vs +$293M in Q4’26) and free cash flow was -$342M, which is a major deterioration in cash conversion.

Leverage & Balance Sheet

Positive

Strong equity base ($2.37B) and net cash position (net debt about -$252M) suggest resilience; total assets rose QoQ despite profitability and cash flow pressure.

Shareholder Returns

Fair

Price performance was modest (+6.8% 1y, -13.8% 6m). Dividends were paid (-$61M) but buybacks were not evident in the quarter; total return profile is mixed.

Analyst Sentiment & Valuation

Neutral

Current price ($162.5) sits above consensus target (~$168.25 is only slightly higher), while P/E (~28.7x) and elevated multiples imply limited valuation support amid earnings/cash flow weakness.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Houlihan Lokey delivered a strong FY2026 performance (revenue +10% to $2.6B; adjusted EPS +20% to $7.56) and reported Q4 revenue of $636M with adjusted EPS of $1.63. The key swing factor in the call was Financial Restructuring: management said activity levels materially increased due to new mandates and changes in market dynamics, flipping prior-quarter conservatism into an improved fiscal 2027 outlook, with elevated levels expected to persist. Corporate Finance faced near-term timing headwinds as geopolitical uncertainty extended deal timelines; management does not expect permanent deterioration, but acknowledges variability into early fiscal 2027. On financial quality, adjusted compensation ratio held at 61.5%, while the effective tax rate fell 610 bps to 23.7% due to policy changes. Capital returns included ~$1.4B cash/investments, ~300k shares repurchased in Q4, and a 17% dividend increase to $0.70/share. Analysts pressed most on restructuring recovery, sponsor/price alignment, and AI’s profitability impact.

AI IconGrowth Catalysts

  • Financial Restructuring momentum returned to more normal levels; elevated activity expected to continue into fiscal 2027.
  • Corporate Finance improved transaction metrics across most industry groups; notable backlog growth, with non-U.S. revenues growing significantly faster than U.S.
  • Capital Solutions strong fiscal 2026 performance entering fiscal 2027 with strong backlog and high expectations.

Business Development

  • Closed fiscal Q4 2026 transactions/partnerships welcoming new colleagues from Audere Partners and Mellum Capital.
  • Promoted 25 colleagues to Managing Director in the first quarter of fiscal 2027.
  • Recent acquisition in France supporting differentiated Europe growth (referenced as adding to Europe business).

AI IconFinancial Highlights

  • FY2026 revenue $2.6B (+10% y/y) and adjusted EPS $7.56 (+20% y/y).
  • Q4 2026 revenue $636M; adjusted EPS $1.63.
  • Corporate Finance Q4 revenue $434M (+5% y/y) with 171 transactions closed vs 147; average transaction fee on closed deals decreased.
  • Financial Restructuring Q4 revenue $110M; FY2026 revenue $529M (-3% y/y) with 30 transactions closed vs 21% lower year-over-year; average transaction fee on closed deals decreased.
  • Financial and Valuation Advisory Q4 revenue $91M (+3% y/y); fee events 1,248 vs 1,224 (+2%).
  • Adjusted compensation expense ratio flat at 61.5% vs prior year; reaffirmed long-term target 61.5% for fiscal 2027.
  • Adjusted effective tax rate FY2026 23.7% vs 29.8% FY2025 (-610 bps); driven by policy change (no longer adjusting out stock compensation deductions).
  • Adjusted effective tax rate Q1 fiscal 2027 benefit expected: about half of Q4 fiscal 2026 adjusted rate (vs vesting of shares at grab prices in May).
  • Non-compensation expenses increased 10.5% to $94M in Q4; FY2026 adjusted non-comp ratio ended at 13.9%, with fiscal 2027 expecting similar growth.

AI IconCapital Funding

  • Repurchased approximately 300,000 shares in Q4 under the share repurchase program.
  • Ended quarter with ~$1.4B cash and investments (cash earmarked to cover accrued but unpaid bonuses for FY2026 paid at month-end in November).
  • Board increased quarterly dividend to $0.70/share (+17% vs fiscal 2026 quarterly dividend); first quarter dividend paid in June.
  • Continues to evaluate balance sheet flexibility for acquisitions vs excess cash for repurchases.

AI IconStrategy & Ops

  • Corporate Finance deal timelines extended due to geopolitical uncertainty from the Middle East; management expects this to persist in the near term and to moderate growth in early fiscal 2027 (similar to Q4 impact).
  • Financial Restructuring Q4 impacted by closing timing (two larger transactions extended beyond quarter end); management does not view fee-size changes as a persistent trend.
  • AI/technology: management is investing across front-end, workflow, operations/back office, and 'moonshot' workstreams; technology spend expected to remain consistent and be transferable across Portfolio Valuation/FDA and benefit Corporate Finance/Restructuring.

AI IconMarket Outlook

  • Corporate Finance: expect deal time-line variability to persist; near-term closing timing may moderate Q1 growth, but full-year trajectory remains encouraging.
  • Financial Restructuring: improved outlook for fiscal 2027 driven by materially increased activity levels and recent wins; management expects elevated levels to continue into fiscal 2027 and 'probably beyond.'
  • Financial and Valuation Advisory: Portfolio valuation marks expected to be needed more regularly in contexts like private credit scrutiny; TAM continuing to grow.
  • Adjusted compensation expense ratio: maintain long-term target 61.5% for fiscal 2027.

AI IconRisks & Headwinds

  • Geopolitical uncertainty (Middle East conflict) extending M&A timelines and creating near-term closing volatility.
  • Technology/software impact: management expects software/technology to be affected in fiscal 2027; timing/demand uncertainty persists as clients assess impact.
  • Private credit valuation pressure could affect deal pricing dynamics and activity velocity (though management emphasized pent-up demand).
  • Pricing pressure in FDA business expected to persist (management reiterated it has existed for a decade), though they argue TAM growth outpacing pricing declines.

Q&A: Analyst Interest

  • Restructuring outlook reversal: Management explained the improved Financial Restructuring outlook is the flip side of Corporate Finance troubles, creating restructuring opportunity. They cited newly seen mandates and materially increased activity since last quarter, plus specific recent wins, leading them to confidence in elevated levels next year and beyond.
  • Sponsor activity/transaction velocity and price alignment: Management described sponsor velocity picking up again at the highest level in years, emphasizing that deal initiation momentum is strong even after Middle East/software-related brakes. They acknowledged some assets may be too far from price differentials, but said most deal flow is not in that category.
  • AI implications for FDA/valuation and cost structure: Management said AI is not new to them; they have been investing for years, including through acquisitions (UK example). They expect pricing pressure to continue but argued TAM growth outpaces pricing declines and consolidation benefits larger technology-investing firms.

Sentiment: MIXED

Note: This summary was synthesized by AI from the HLI Q4 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for HLI.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (HLI)

© 2026 Stock Market Info — Houlihan Lokey, Inc. (HLI) Financial Profile